EUVIMEDEUVIMED entdecken
Crossref

The Protective Effects of Saxagliptin and Cilostazol in an Experimental Model of Cyclophosphamide‐Induced Nephrotoxicity in Rats: Targeting iNOS/ NF ‐ kB and Nrf‐2 / HO‐1 Pathways

Monira A Seleem, Ola M Salem, Eman Basha, Hoda A Ibrahim, Amira Mostafa Elshamy, Asmaa R Azzam, Radwa Ismail, Abdallah A Homouda, Alaa Elkordy, Heba Faheem

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Monira A Seleem und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Faculty of Medicine, Tanta University, Tanta, Egypt. Hauptthemen laut MEDLINE: Dipeptides, NF-kappa B, Adamantane, Cyclophosphamide. Die Arbeit nennt 43 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclophosphamide (CYP) is an extensively used immunosuppressive drug and chemotherapeutic agent for various malignancies. Nevertheless, its use is limited due to adverse effects, including nephrotoxicity. Saxagliptin is a DPP4 inhibitor, while cilostazol serves as an antiplatelet agent. Their nephroprotective effects arise from antioxidant and anti‐inflammatory properties. This study investigated the potential protective effects of Saxagliptin and Cilostazol in rats with kidney damage induced by CYP. Five equal groups of 50 male Wistar rats were randomly categorised as Group I (Control group), Group II: CYP untreated nephrotoxicity–induced group, Group III: Nephrotoxicity‐induced group treated with saxagliptin, Group IV: Nephrotoxicity‐induced group treated with cilostazol, and Group V: Nephrotoxicity‐induced group treated with saxagliptin and cilostazol. Renal tissues and blood samples were collected for biochemical analysis of urea, creatinine, and acute kidney injury biomarkers, including Kim‐1 and NGAL. Additionally, oxidative stress and inflammatory biomarkers such as GSH, MDA, TNF‐α and IL‐1β were assessed, along with gene expression of Nrf‐2/HO‐1 and NF‐kB . Immunohistochemical analysis of iNOS, and histopathological study were also conducted. Saxagliptin and cilostazol ameliorated the nephrotoxicity induced by CYP, as indicated by improvements in urea, creatinine, and acute kidney injury biomarkers Kim‐1 and NGAL. Furthermore, there was a decrease in oxidative stress via the upregulation of Nrf‐2/HO‐1 , increased levels of GSH, downregulation of MDA and decreased inflammation via the downregulation of TNF‐α, IL‐1β and iNOS/ NF‐kB . The combination of saxagliptin and cilostazol demonstrated a significant improvement compared to using each agent individually. The combination of Saxagliptin/Cilostazol is superior to monotherapy by either of each alone in preventing CYP‐induced nephrotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DipeptidesNF-kappa BAdamantaneCyclophosphamideNF-E2-Related Factor 2CilostazolNitric Oxide Synthase Type IISignal TransductionAcute Kidney InjuryAnimalsMaleRats, WistarRatsHeme Oxygenase (Decyclizing)Disease Models, AnimalOxidative StressKidney

Stichwörter der Autor:innen

CYPNF‐kBNrf‐2cilostazolnephrotoxicitysaxagliptin

Substanzen

saxagliptinDipeptidesNF-kappa BAdamantaneCyclophosphamideNF-E2-Related Factor 2Nfe2l2 protein, ratCilostazolNitric Oxide Synthase Type IIHmox1 protein, rat

Autor:innen und Institutionen

  • Department of Medical Pharmacology, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Department of Physiology, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Department of Basic Medical Sciences, Physiology, Faculty of Medicine, Ibn Sina University for Medical Sciences, Amman, Jordan.
  • Department of Medical Biochemistry, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Department of Anatomy and Embryology, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Department of Urology, Faculty of Medicine, Tanta University, Tanta, Egypt.

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Seleem, M. A., Salem, O. M., Basha, E., Ibrahim, H. A., Elshamy, A. M., Azzam, A. R., Ismail, R., Homouda, A. A., Elkordy, A., & Faheem, H. (2025). The Protective Effects of Saxagliptin and Cilostazol in an Experimental Model of Cyclophosphamide‐Induced Nephrotoxicity in Rats: Targeting iNOS/ NF ‐ kB and Nrf‐2 / HO‐1 Pathways. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70196

Vancouver

Seleem MA, Salem OM, Basha E, Ibrahim HA, Elshamy AM, Azzam AR, et al. The Protective Effects of Saxagliptin and Cilostazol in an Experimental Model of Cyclophosphamide‐Induced Nephrotoxicity in Rats: Targeting iNOS/ NF ‐ kB and Nrf‐2 / HO‐1 Pathways. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70196

BibTeX
@article{Seleem2025,
  author = {Seleem, Monira A and Salem, Ola M and Basha, Eman and Ibrahim, Hoda A and Elshamy, Amira Mostafa and Azzam, Asmaa R and Ismail, Radwa and Homouda, Abdallah A and Elkordy, Alaa and Faheem, Heba},
  title = {The Protective Effects of Saxagliptin and Cilostazol in an Experimental Model of Cyclophosphamide‐Induced Nephrotoxicity in Rats: Targeting iNOS/ NF ‐ kB and Nrf‐2 / HO‐1 Pathways},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70196}
}
Kostenlos starten →